HCV co-infection in HIV positive population in British Columbia, Canada

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Buxton, Jane A ^a,b   Yu, Amanda ^a,b   Kim, Paul H ^a   Spinelli, John J ^b,c   Kuo, Margot ^a   Alvarez, Maria ^a   Gilbert, Mark ^a,b   Krajden, Mel ^a  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AMERICAN INDIAN; ARTICLE; CANADA; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; HEALTH SURVEY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PREVALENCE; SEXUAL BEHAVIOR; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRITISH COLUMBIA; FEMALE; HEPATITIS C; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 77951539262     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-225     Document Type: Article

References (31)

1. Management of chronic hepatitis C: consensus guidelines. M Sherman S Shafran K Burak K Doucette W Wong N Girgrah E Yoshida E Renner P Wong M Deschenes, Can J Gastroenterol 2007 21 Suppl C 25C 34C 17568824 (Pubitemid 47177083)
2. CHASE Project Team, Community Health and Safety Evaluation (CHASE) Project: Final Report 2005 http://chase.hivnet.ubc.ca/project/pubdocs/CHASE- Reports/CHASE-Final-Report.pdf Downloaded April 13, 2010
3. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility. E Wood T Kerr J Stoltz Z Qui R Zhang JS Montaner MW Tyndall, Public Health 2005 119 1111 1115 10.1016/j.puhe.2005.05.006 16214189
4. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. CL Miller E Wood PM Spittal K Li JC Frankish P Braitstein JS Montaner MT Schechter, J Acquir Immune Defic Syndr 2004 36 743 749 10.1097/00126334-200406010-00012 15167294
5. Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illness. MS Sulkowski DL Thomas, AIDS 2005 19 Suppl 3 8 12 10.1097/01.aids.0000192064.09281.48 16251833
6. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. JA Pineda M Romero-Gomez F Diaz-Garcia JA Giron-Gonzalez JL Montero J Torre-Cisneros RJ Andrade M Gonzalez-Serrano J Aguilar M Aguilar-Guisado JM Navarro J Salmerán FJ Caballero-Granado JA García-García, Hepatology 2005 41 779 789 10.1002/hep.20626 15800956
7. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. G Antonucci E Girardi A Cozzi-Lepri MR Capobianchi G Morsica P Pizzaferri N Ladisa L Sighinolfi A Chiodera M Solmone E Lalle G Ippolito A Monforte HepaICoNA Study Group ICoNA Study Group, Antivir Ther 2005 10 109 117 15751768
8. HCV coinfection hastens HIV disease progression. M Carter, IAPAC Mon 2004 10 433 15744893
9. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. RC Hershow PT O'Driscoll E Handelsman J Pitt G Hillyer L Serchuck M Lu KT Chen S Yawetz S Pacheco K Davenny S Adeniyi-Jones DL Thomas, Clin Infect Dis 2005 40 859 867 10.1086/428121 15736020
10. Management of Hepatitis C in HIV-infected Patients. B Rodriguez DA Bobak, Curr Infect Dis Rep 2005 7 91 102 10.1007/s11908-005-0067-0 15727735
11. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. L Aranzabal JL Casado J Moya C Quereda S Diz A Moreno L Moreno A Antela MJ Perez-Elias F Dronda A Marín F Hernandez-Ranz A Moreno S Moreno, Clin Infect Dis 2005 40 588 593 10.1086/427216 15712082
12. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy. D Fuster R Planas R Muga AL Ballesteros J Santos J Tor G Sirera H Guardiola A Salas E Cabre I Ojanguren E Barluenga C Rey-Joly B Clotet C Tural, AIDS Res Hum Retroviruses 2004 20 1293 1297 10.1089/aid.2004.20.1293 15650421
13. Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals. P Cote JG Baril MN Hebert M Klein R Lalonde M Poliquin D Rouleau R Therrien S Vezina B Willems H Dion P Junod N Lapointe D Lévesque L Pinault C Tremblay B Trottier S Trottier C Tsoukas A Piché Can J Infect Dis Med Microbiol 2007 18 293 303 18923731
14. Challenges in the management of HIV and hepatitis C virus co-infection. W Lee D Dieterich, Drugs 2004 64 693 700 10.2165/00003495-200464070-00002 15025544 (Pubitemid 38471371)
15. Peginterferon-alpha-2a (40 kD) plus ribavirin: a review of its use in hepatitis C Virus And HIV co-infection. GL Plosker GM Keating, Drugs 2004 64 2823 2843 10.2165/00003495-200464240-00009 15563253
16. Hepatitis C and HIV infection: biological, clinical, and therapeutic implications. V Soriano J Garcia-Samaniego R Rodriguez-Rosado J Gonzalez J Pedreira, J Hepatol 1999 31 Suppl 1 119 123 10.1016/S0168-8278(99)80387-0 10622573
17. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. M Bonacini M Puoti, Arch Intern Med 2000 160 3365 3373 10.1001/archinte.160.22.3365 11112228
18. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. O Lesens M Deschenes M Steben G Belanger CM Tsoukas, J Infect Dis 1999 179 1254 1258 10.1086/314720 10191232
19. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Y Benhamou M Bochet MV Di F Charlotte F Azria A Coutellier M Vidaud F Bricaire P Opolon C Katlama T Poynard, Hepatology 1999 30 1054 1058 10.1002/hep.510300409 10498659 (Pubitemid 29458296)
20. Treatment of hepatitis C in HIV/hepatitis C co-infected patients: what is the evidence? P Cacoub, Int J STD AIDS 2005 16 1 4 10.1258/0956462052932737 15705263
21. Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations. M Romero M Perez-Olmeda J Garcia-Samaniego V Soriano, Drug Saf 2004 27 7 24 10.2165/00002018-200427010-00002 14720084
22. Hepatitis C in the HIV-infected patient. MS Sulkowski DL Thomas, Clin Liver Dis 2003 7 179 194 10.1016/S1089-3261(02)00074-0 12691466
23. Acute hepatitis C. A Maheshwari S Ray PJ Thuluvath, Lancet 2008 372 321 32 10.1016/S0140-6736(08)61116-2 18657711
24. Pathogenesis, natural history, treatment, and prevention of hepatitis C. TJ Liang B Rehermann LB Seeff JH Hoofnagle, Ann Intern Med 2000 132 296 305 10681285
25. HAART and Liver: a discussion of hepatic disease in those living with HIV. Interview by Paul C Adams. C Cooper, Can J Gastroenterol 2008 22 973 975 19096734
26. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. NJ Bodsworth P Cunningham J Kaldor B Donovan, Genitourin Med 1996 72 118 122 8698359
27. The prevalence and correlates of hepatitis C virus (HCV) infection and HCV-HIV co-infection in a community sample of gay and bisexual men. T Myers D Allman K Xu RS Remis J Aguinaldo A Burchell L Calzavara C Swantee, Int J Infect Dis 2009 13 730 9 10.1016/j.ijid.2008.11.015 19186090
28. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AT Urbanus TJ van de Laar IG Stolte J Schinkel T Heijman RA Coutinho M Prins, AIDS 2009 23 1 F7 10.1097/QAD.0b013e32832e5631 19542864
29. Hepatitis C-seroconversion within three to six months after having contracted clinical syphilis and/or lymphogranuloma venereum rectitis in five homosexually active, HIV seropositive men. JM Pelgrom D Vogelaers I Colle, Acta Clin Belg 2008 63 335 338 19186567
30. A cluster of acute hepatitis C virus infection among men who have sex with men - results from contact tracing and public health implications. HM Gotz G van Doornum HG Niesters JG den Hollander HB Thio O de Zwart, AIDS 2005 19 969 974 10.1097/01.aids.0000171412.61360.f8 15905679
31. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. BC Van Den C Smit G Van Brussel R Coutinho M Prins, Addiction 2007 102 1454 1462 10.1111/j.1360-0443. 2007.01912.x 17697278